Study shows that there is slower cancer drug approval in Europe

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Ibrutinib plus venetoclax for 1-L treatment of CLL and small lymphocytic lymphoma shows a clinically meaningful PFS

Rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian cancer

RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies

ASCO 2022: Testing and diagnostics in EGFR exon 20 insertion positive NSCLC

ASCO and WHO to collaborate on quality indicators for cancer facilities

CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma

Treatment with high-dose multi-agent chemotherapy for high-risk lymphoma is effective but with significant toxicity

Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients